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The intestinal epithelium consists of a single cell layer, which is a critical selectively
permeable barrier to both absorb nutrients and avoid the entry of potentially harmful
entities, including microorganisms. Epithelial cells are held together by the apical
junctional complexes, consisting of adherens junctions, and tight junctions (TJs), and
by underlying desmosomes. TJs lay in the apical domain of epithelial cells and are
mainly composed by transmembrane proteins such as occludin, claudins, JAMs, and
tricellulin, that are associated with the cytoplasmic plaque formed by proteins from the
MAGUK family, such as ZO-1/2/3, connecting TJ to the actin cytoskeleton, and cingulin
and paracingulin connecting TJ to the microtubule network. Extracellular bacteria such
as EPEC and EHEC living in the intestinal lumen inject effectors proteins directly from
the bacterial cytoplasm to the host cell cytoplasm, where they play a relevant role in
the manipulation of the eukaryotic cell functions by modifying or blocking cell signaling
pathways. TJ integrity depends on various cell functions such as actin cytoskeleton,
microtubule network for vesicular trafficking, membrane integrity, inflammation, and cell
survival. EPEC and EHEC effectors target most of these functions. Effectors encoded
inside or outside of locus of enterocyte effacement (LEE) disrupt the TJ strands.
EPEC and EHEC exploit the TJ dynamics to open this structure, for causing diarrhea.
EPEC and EHEC secrete effectors that mimic host proteins to manipulate the signaling
pathways, including those related to TJ dynamics. In this review, we focus on the known
mechanisms exploited by EPEC and EHEC effectors for causing TJ disruption.
Keywords: cell junction, occludin, claudin, ZO-1, Enteropathogenic E. coli, Enterohemorrhagic E. coli, T3SS
effectors, tight junction
INTRODUCTION
The intestinal epithelium is the largest mucosal surfaces of the body, covering about 400 m2 of
surface area with a single layer of cells organized into crypts and villi. This surface is continually
renewed by pluripotent intestinal epithelial stem cells that reside in the base of crypts (van der Flier
and Clevers, 2009). The intestinal epithelium constitutes the most important barrier against the
external environment, represented by the intestinal lumen (Farhadi et al., 2003). The epithelium
acts as a selectively permeable barrier, permitting the absorption of nutrients, electrolytes, and
water contained in the intestinal lumen, while maintaining an effective defense against intraluminal
toxins, antigens, and enteric flora. The intestinal epithelium contains five distinct types of cells:
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stem cells with interposed Paneth cells producing antimicrobial
peptides, absorptive enterocytes, goblet cells secreting mucus,
and enteroendocrine cells producing hormone (Kraehenbuhl
et al., 1997). The intestinal epithelium mediates selective
permeability through two major pathways, the transcellular
and paracellular route (Tsukita et al., 2001). Transcellular
permeability is generally associated with solute transport through
the epithelial cells and predominantly regulated by selective
transporters for amino acids, electrolytes, short-chain fatty acids,
and sugars (Ferraris and Diamond, 1997; Kunzelmann and Mall,
2002; Broer, 2008). Paracellular permeability is associated with
the transport in the space between epithelial cells, and it is
regulated by intercellular complexes localized at the apico-lateral
membrane junction and along the lateral membrane (Van Itallie
and Anderson, 2006).
Epithelial cells are held together by the apical junctional
complexes, consisting of adherens junctions (AJs) and tight
junctions (TJs), and by underlying desmosomes (Suzuki, 2013).
The AJs, along with desmosomes, provide strong adhesive
bonds between the epithelial cells, and also help intercellular
communication, but do not determine paracellular permeability
(Nekrasova and Green, 2013). The TJs circumscribe the apical
ends of the lateral membranes of epithelial cells and determine
the selective paracellular permeability to solutes (Van Itallie
and Anderson, 2006). Thereby, the TJs provide both a barrier
to harmful molecules and a pore for the permeation of
ions, solutes, and water as appropriate. TJs are comprised of
four transmembrane proteins, claudins (Furuse et al., 1998),
occludin (Furuse et al., 1993), junctional adhesion molecules
(JAMs) (Martin-Padura et al., 1998), and tricellulin (Ikenouchi
et al., 2005), and some cytosolic scaffold proteins, such as
zonulae occludens (ZO), and cingulin (Lee, 2015). TJ proteins
interact with the actin cytoskeleton for maintaining TJ structure
(Figure 1) and this interaction permits the cytoskeletal regulation
of TJ barrier integrity (González-Mariscal et al., 2003). At
the same time, the circumferential contraction and tension in
the actin is regulated by myosin light chain (MLC) activation
(Turner et al., 1997). MLC phosphorylation induced by kinases
such as MLC kinase (MLCK) and Rho-associated kinase causes
the contraction of the actin, resulting in the opening of the
paracellular pathway (Walsh et al., 2001). Intestinal permeability
is a dynamic process and its regulation is determined by
the interaction among several participants, such as barrier
constituents, immune cells, microbiota, and also external factors,
including the diet. Alterations of mucosal barrier function are
increasingly linked to a broad spectrum of pathologies, such as
nonalcoholic fatty liver disease (Miele et al., 2009), type 1 diabetes
(Bosi et al., 2006) and chronic intestinal inflammation (Pastorelli
et al., 2013).
Thus, through all these protein complexes, the TJs are
found in the most apical part of the epithelial cells restricting,
among other factors, the entry of most of the microorganisms
living or colonizing the intestinal mucosa. However, diverse
pathogens have generated a number of strategies to disrupt
these protein structures and spread to various tissues. Different
pathogens produce virulence factors associated to TJ disruption.
For instance, viruses as the Hepatitis C use occludin in the initial
steps of their internalization (Ploss et al., 2009), or claudin-1
in the last steps of virus internalization (Evans et al., 2007).
Fungi as Aspergillus and Penicillium produce ochratoxin A,
which disrupts the epithelium permeability by removing specific
isoforms of claudin from the TJs (McLaughlin et al., 2004).
Parasites as Entamoeba histolytica produce a cysteine protease
(EhCP-A5), which induces a proinflammatory response that is
related to an increase in the TJ permeability (Kissoon-Singh
et al., 2013). Manipulation of TJs is not exclusive of viruses,
fungi or parasites, pathogenic bacteria also produce virulence
factors for targeting the TJs. For example, Helicobacter pylori
injects, through the type 4 secretion system, the CagA protein
into the cytoplasm of gastric epithelial cells. CagA associates
with ZO-1 and JAM causing assembly of TJ components at
the sites of attached bacteria, altering the composition and
function of the apical junction complex (Amieva et al., 2003).
Other bacterial pathogens use similar strategies for translocating
proteins, called effector proteins, to the cytoplasm of the
host cells to disrupt the TJ integrity. Enteropathogenic and
enterohemorrhagic Escherichia coli (EPEC and EHEC) are
members of a family of bacterial pathogens with the capability
of causing a histopathological lesion called attaching and effacing
lesion (A/E lesion). Bacterial pathogens causing this lesion are
collectively named as A/E pathogens and also include Citrobacter
rodentium, Hafnia alvei and EPEC affecting animals such as
rabbit (REPEC). A/E lesions are characterized by effacement
of the brush border microvilli, intimate bacterial adherence to
the enterocyte apical plasma membrane, and the accumulation
of polymerized actin beneath the attached bacteria (Knutton
et al., 1987). In order to manipulate the actin cytoskeleton,
EPEC, and EHEC inject, by a type 3 secretion system (T3SS),
effector proteins, which are able to hijack the host cell machinery
interfering with host cell pathways and with a number of
actin binding proteins. The actin cytoskeleton is a dynamic
structure necessary for cell and tissue organization (Navarro-
Garcia et al., 2013), including the maintenance of epithelial
barriers.
For generating the A/E lesion or pedestal-like structure, EPEC
and EHEC manipulate transduction signaling pathways of the
host cells to produce this lesion. EPEC and EHEC use various
proteins that are encoded in a chromosomal pathogenicity island
(PAI) known as the locus of enterocyte effacement (LEE). This
PAI is shared by the other A/E pathogens and encodes factors
needed for the pathogenesis of EPEC/EHEC, including the
diarrhea production (McDaniel and Kaper, 1997). Inside LEE
PAI are genes encoding for proteins of the T3SS, including
translocator proteins such as EspA, EspB, and EspD (Hartland
et al., 2000), which are used by EPEC/EHEC to inject effector
proteins inside the host cell. LEE also encodes for effector
proteins such as Tir, EspF, EspG, EspZ, EspH, and Map (Wong
et al., 2011), gene regulators such as Ler (LEE-encoded regulator)
(Elliott et al., 2000), chaperone proteins such as CesT for Tir,
(Abe et al., 1999), CesD for EspB and EspD (Wainwright and
Kaper, 1998), and CesF for EspF (Elliott et al., 2002). Additional
to LEE effector proteins, exist other effector proteins that are
encoded outside of LEE, known as non-LEE encoded effectors,
such as NleA/EspI, NleB, NleC, NleD, NleE, EspJ, NleH, EspG,
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FIGURE 1 | Schematic representation of the basic structural transmembrane and peripheral membrane components of tight junctions (TJs). TJs are
the most apical intercellular junctions in epithelial cells (lower insert). TJs consist of a complex interaction of three core protein components: (i) transmembrane proteins
(occludin, claudins, junctional adhesion molecules [JAM] and tricellulin) (ii) Accessory proteins (Zonulae occludins 1–3), and (iii) cytoskeletal proteins (actin etc.).
Changes in the expression and location of these proteins can lead to significant changes in the epithelial barrier function. Upper insert shows a transversal view of
three cells bound by TJs, highligting the role of tricellulin junction.
EspM, and Cif (Dean and Kenny, 2009; Vossenkamper et al.,
2011; Salvador et al., 2014).
Most of the subversions by these effectors are related to the
cell cytoskeleton modification, TJs disruption, cell death, and
inflammation. Various effector proteins mimic epithelial cell
proteins through different cellular pathways. In this review, we
will focus on the molecular strategies used by EPEC and EHEC
to disrupt the TJs.
DISASSEMBLY OF TJs BY EPEC AND
EHEC
Classically, TJs integrity is evaluated by measuring the
transepithelial electrical resistance (TEER). The electrical
impedance allows measuring the continuous current passing
through the cells on both transcellular and paracelllular
pathways. The transcellular resistance is due to the apical
and basolateral plasma membrane, while the paracellular
resistance results of cell-substrate and cell-cell contacts. As
mentioned above, specific TJs proteins principally influence
the epithelial resistance. Thereby, the TEER values reflects the
electrophysiological properties due to the physical structures
and properties of filter-grown epithelial cultures (Chen et al.,
2015). Thus, TEER measurement has been one of the main
tools for determining the permeability of TJs or membrane
perturbation by disruptors of intestinal and kidney epithelial
cells lines (Madgula et al., 2007).
It has been described that EPEC/EHEC alter the TJ
permeability and thereby the TEER. EPEC infection using
T84 monolayers showed that bacteria are able to disrupt the
TEER due to the TJ disruption by assessing the mannitol
flux (Spitz et al., 1995). These defects in the epithelial barrier
induced by EPEC infection cause an increase of the monolayer
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permeability and atypical distribution of ZO-1 (Philpott et al.,
1996). Subsequently to this atypical distribution of ZO-1 induced
by EPEC, other TJ proteins as occludin and claudin have been
found to be redistributed. In fact, EPEC infection induces
occludin dephosphorylation and its relocalization from TJs to
intracellular compartments of T84 cells (Simonovic et al., 2000).
Similarly, claudin distribution is affected by EPEC infection in
T84 cells (Muza-Moons et al., 2004) and by using amurine model
in vivo infected with EPEC (Zhang et al., 2012).
Like EPEC, EHEC generates a TEER decrease, and this
decrease is independent of the Stx action. Indeed, T84
monolayers treated with purified Stx do not show a TEER
decrease; however, damage to barrier function is used as a form
of the toxin translocation (Philpott et al., 1997). Redistribution
of TJ proteins is also found during the infection of EHEC.
Contrary to the distribution of ZO-1 and TJ disruption, there is
no disruption of the AJ protein E-cadherin during the infection
by EHEC (Philpott et al., 1998). Interestingly, an acute model of
infection by EHEC showed a rapid disruption of TJs, while the
chronic infection by EHEC produced a change in the expression
of claudins, favoring a phenotype of high permeability, which was
independent of Stx1 (Roxas et al., 2010).
The ability of EPEC/EHEC for decreasing TEER and causing
altered distribution of TJ proteins has been attributed to diverse
proteins encoded in the LEE PAI. The insertion of the LEE
PAI in a non-pathogenic E. coli K12 confers the capability for
producing changes in the localization of occludin. Moreover,
a mutant strain in structural genes of the T3SS is unable to
cause the altered localization of occludin (Simonovic et al., 2000).
These data suggest that the genes encoded in LEE, as well as a
functional T3SS are required to produce changes in TJs integrity.
Additionally, some effectors encoded in LEE such as EspF, Map,
and EspG, as well as non-LEE effectors, such as NleA and EspM,
have been involved in the altered distribution of TJ proteins
(Figure 2), and thereby in the production of diarrhea due to the
infection by EPEC and EHEC.
EFFECTORS ENCODED IN LEE
EspF
E. coli secreted protein F (EspF) was identified based on the
proline-rich repeats (PRR) in its amino acid sequence, very
similar to eukaryotic motifs. Each of these PRRs comprises a
putative motif of src homology 3 (SH3) ligand binding domains,
which have been reported that mediate protein interaction and
are found in a variety of eukaryotic proteins that participate in
various signaling networks (McNamara and Donnenberg, 1998).
On the other hand, EHEC produces various effector proteins
with similarity to EPEC EspF including EHEC EspF (87% of
similarity), EspFu/TccP (24% of similarity), and M-EspF (28% of
similarity). Another important difference among these proteins
is the number of PRR; EHEC EspF contains four, while EspFu
and M-EspF contain seven and five, respectively (Viswanathan
et al., 2004). It has been found that these PRR motifs specifically
interact with SH3 domains of the eukaryotic protein SNX9
(Sorting Nexin 9), inducing tubules formation in the host cell
membrane (Alto et al., 2007). Although the function of these
tubules has not been discovered, Weflen et al. proposed that
EPEC EspF uses SNX9 to promote the invasion of neighboring
epithelial cells (Weflen et al., 2010). Within the PRR sequence
of EPEC EspF there is also a putative domain like the binding
domain to Cdc42/Rac (CRIB) of N-WASP. EspF PRRs stimulate
actin nucleation mediated by the N-WASP/Arp2/3, possibly by
binding to CRIB autoregulation domain of N-WASP (Alto et al.,
2007).
In recent years EPEC and EHEC EspF have been classified
as multifunctional bacterial effectors that manipulate diverse
cellular processes such as antiphagocytic processes, elimination
of intestinal microvilli, remodeling of the host cell membrane,
modulation of the cytoskeleton dynamics, destruction of the
nucleolus, elimination of intermediate filamentous, cellular
invasion, mitochondrial dysfunction, cell death by apoptosis,
inhibition of important epithelial transporters, as well as
disruption of the epithelial barrier (Holmes et al., 2010).
In 2001, MacNamara et al. reported the first finding relating
EspF with disruption of epithelial barrier; an espF mutant was
deficient for disrupting TEER of T84 monolayers. This espF
mutant was also unable to induce increase in epithelial flux of
mannitol, a marker of paracellular permeability, and was unable
to distribute occludin from the TJs (McNamara et al., 2001). On
the other hand, EHEC EspF appears to play a more moderate
role in the transepithelial barrier, since neither a mutation on
espF nor cesF (gene for the EspF chaperone) in EHEC prevented
the loss of TEER induced by EHEC. However, EHEC EspF and
EspFu complemented to an espF mutant in EPEC (EPEC1espF)
for restoring the ability to disrupt the TEER and occludin
redistribution. Additionally, it has been noticed that EspFu
increases the TJ disruption, since when EHEC is transformed
with a high expression plasmid containing espFu/tccp, the
high expression of this protein increases the TJ disruption in
comparison with the EHEC wild type strain (Viswanathan et al.,
2004).
During EPEC infection on T84 monolayers, TJ perturbation
can result from disruption of protein-protein interactions.
Although, the protein concentration is kept constant, EPEC
produces a disorganized distribution of claudin 1, occludin and
ZO-1, which leads to progressive loss of TEER. This loss in
TEER is correlated with aberrant strands in the lateral membrane
(Muza-Moons et al., 2004). These data have been consistent
using an in vivo mouse model. EPEC wild type caused occludin
redistribution and considerably diminished the intestinal barrier
functions of the ileum and colonic mucosa (Shiﬄett et al., 2005).
Thus, EPEC opens the TJ strands in an EspF-dependent way, a
process that is extremely related to diarrhea production.
Diverse stimulus, including calcium reduction, TNF-α, IFN-γ,
and epidermal growth factor (EGF), rapidly modify the structure
of the TJ strands. The dynamic behavior of TJs includes the
movement of TJ strands and of individual TJ proteins, which
can migrate within the TJ and in and out of these structures.
Some TJ proteins are continually endocytosed and recycled
back to the plasma membrane. Regulation of the endocytic
trafficking of TJ proteins may provide a rapid way for remodeling
of TJs (Chalmers and Whitley, 2012). In this context, during
an infection, EPEC is able to manipulate vesicular trafficking
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FIGURE 2 | Different mechanisms for tight junction (TJs) opening by EPEC and EHEC effector proteins. Disassembly of TJs by the main LEE and non-LEE
effectors injected by the EHEC and EPEC T3SS into the epithelial cells. The main mechanisms for TJ disassembly include actin rearrangement, occludin
de-phosphorylation, microtubule network disruption; COPII mediated trafficking inhibition, vesicle traffic disruption, and inhibition of the TJ proteins renewal. Besides
the shared effectors (EspF, EspG, Map, NleA) by EHEC and EPEC, EHEC infection (left side) also includes EspFu and EspM1/2.
dynamics of TJ proteins not only for destabilization of TJ strands
but also for growing of actin-rich pedestals. A clear example is
ZO-1, which is generally accumulated in the intracellular region
of the TJ but not in other actin-rich structures such as stress
fibers or filopodia. However, it was reported that during EPEC
infection, ZO-1 is recruited to the actin-rich pedestals, and this
incorporation was dependent of proline-rich region of ZO-1
(Hanajima-Ozawa et al., 2007). Additionally, in a model using
RK13 cells from rabbit kidney, other TJ proteins have been
found in the actin-rich pedestals induced by REPEC. REPEC
EspF causes disruption of TJ strands and the recruitment of the
transmembrane proteins claudin and occludin and the proteins
from the cytoplasmic plaque ZO-1 and ZO-2 to the actin-rich
pedestals. Interestingly, espF mutant in REPEC does not cause
disruption of the TJ strands and as a consequence, the cells
produce smaller pedestals than those induced by the EPEC wild
type. Although the exactmechanism of EspF-mediated TJ protein
redistribution is yet to be defined, in silico analyses have revealed
that EspF contains putative SH3 and PDZ domain binding
motifs, whichmay have a crucial role in the interaction with some
promoter factors of actin nucleation as well as with proteins of
the TJ containing PDZ domains. Indeed, REPEC EspF interacts
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with profilin, N-WASP, as well as with ZO-1 and ZO-2 and with
actin. It has been suggested that the interaction of REPEC EspF
with these nucleation factors may be related to an imbalance in
actin polymerization-depolymerization cycles and in this way,
being related to endocytosis of TJ proteins (Peralta-Ramirez et al.,
2008).
In a similar way, in silico analyses and yeast double hybrid
assays, Blasche et al. found a group of proteins associated to actin
that interact with EHEC EspF, such as Arp2, profilin, N-WASP,
and ZO-1/ZO-2. Additionally, various proteins containing BAR-
like domains interact with EHEC EspF such as SNX9 and
SNX33 (Blasche et al., 2014). A relationship between proteins
with BAR-like domains and the pedestal maturation induced
by EHEC has been recently found. TOCA1, FBP17, and CIP4
are BAR domain containing proteins that regulate membrane
dynamics through the ability for causing membrane tubulation.
Campellone et al. found that TOCA1 positively contributes in the
pedestal biogenesis mediated by EspFu, while FBP17 (probably
CIP4) plays an inhibitory role in the pedestal assembly. The
interaction of EspFu with SH3 domain of TOCA1 is implicated
in an increased actin polymerization by N-WASP (Campellone
et al., 2012). Additionally, it has been demonstrated that some
proteins regulating the membrane dynamics, mainly TOCA1,
also regulate TJ assembly. Van Itallie et al. found that PDZ
domain of TOCA1 interacts with ZO-1, leading to N-WASP
and its actin regulation machinery directly to the TJs. Besides,
the TOCA1 knockout results in an increase of the paracellular
flux and suppresses the membrane junction dynamics, which
are believed to be required for keeping the seals in the cell-cell
contacts (Van Itallie et al., 2015).
Map
The mitochondrial associated protein (Map) is an effector
dependent on T3SS, which was detected in supernatants from
EPEC wild type strain, but not in supernatants from a strain
mutant in orf19 gene or in a strain lacking the T3SS. Once inside
the mitochondria, Map causes disruption of the mitochondrial
membrane potential in HeLa cells. Map also interferes with
ATP generation, inhibiting the oxidative phosphorylation that
is mediated by the enzyme succinate dehydrogenase (SDH) in a
murine model and C. rodentium. Thus, Map activity contributes
in the intestinal mucosa damage through destabilizing the
mitochondrial structure, as well as the respiratory chain of
infected epithelial cells (Ma et al., 2006).
Additionally, Map transiently directs the formation of
filopodia in the EPEC adherence site on the HeLa cell membrane,
a process that is independent of the mitochondrial localization.
Also, Map contains a classical motif of PDZ1 binding domain,
with the consensus sequence VQDTRL, which is implicated
in microvilli remodeling in Caco-2 cells infected with EPEC.
This motif is related to the interaction of Map with the
protein Ebp50/NHERF1 (ezrin/radixin/moesin (ERM)-binding
phosphoprotein 50/Na+/H+ exchanger regulatory factor 1).
Ebp50 is one of the surface microvilli components that directs
membrane receptors to the apical membrane, specifically, it
directs Map to the plasma membrane by using the motif
VQDTRJ, a PDZ ligand of Map. Once in the membrane, Map
uses a novel motif of bacterial origin with the consensus sequence
WxxxE to mimic GTPases that activates small G protein Cdc42,
which in turn activates filopodia formation mediated by EPEC
(Kenny et al., 2002; Alto et al., 2006). These initiating events
between Ebp50 and Map trigger an actin-based positive feedback
loop, leading to initial Cdc42 polarization and a subsequent burst
of actin polymerization at the site of bacterial infection (Orchard
et al., 2012). As demonstrated by Berger et al. Map has the same
function in EPEC and EHEC (Berger et al., 2009).
Map also has the ability to induce other effects related to
diarrhea production. EPEC mutated in map gene was strongly
deficient for decreasing TEER, in comparison with the EPECwild
type that rapidly decreased the TEER. This effect of Map on the
TEER is independent of Map localization in the mitochondria
(Dean and Kenny, 2004). Occludin forms a continuous perimeter
band in the apical region, and this distribution is kept in cells
infected with a EPEC strains with a mutation in map gene,
implicating Map in the epithelial barrier dysfunction mediated
by EPEC and giving to Map an important role in the diarrhea
produced by EPEC (Dean and Kenny, 2004).
EspG
The espG gene encodes for a protein that is secreted and
translocated by the T3SS. espG is highly conserved in LEE from
EPEC (E2348/69) and EHEC O157:H7 with an identity of 98%.
EspG protein also has a significant homology (21% identity and
40% similarity) with VirA, a protein secreted by the T3SS of
Shigella flexneri. Additionally, there is an EspG homolog, named
EspG2, which is encoded far away from LEE (Elliott et al., 2001).
The important role of EspG of EHEC as a regulator of
endomembrane trafficking has been reported. For carrying
out this process, EspG uses as substrates the eukaryotic
proteins ARF (ADP-ribosylation factor), a GTPase related to the
organization of the vesicle transport, as well as uses as substrate
PAK proteins (p21-activated kinases), which are implicated
in the signal transduction mediated by the GTPases Cdc42
and Rac1 that establish intracellular polarity (Germane and
Spiller, 2011; Selyunin et al., 2011). EspG targets ARF in the
active conformation, ARF-GTP. EspG-ARF interaction blocks
the access of GAPs (GTPase activating proteins), preventing
the hydrolysis of ARF-GTP in the γ-phosphate of GTP and
perturbing the normal cycling of guanines (Selyunin et al.,
2011). Additionally, EspG-ARF-GTP forms a ternary complex
with Rab1, severely interrupting the host secretory pathway.
EspG harbors a TBC-like dual-finger motif and exhibits potent
RabGAP activities (Dong et al., 2012). The interaction of PAK2
with EspG is strictly dependent on the EspG-ARF1-GTP complex
and ARF tethering to the membrane. Once these three factors are
bound, PAK2 activity increases 7.6 times. EspG-PAK interaction
blocks the binding to PAK substrates, by blocking the catalytic
site, thereby stabilizing the homodimer structure (Selyunin et al.,
2011). The interaction of EspG with Rac/Cdc42(p21) binding
domain of PAK1, mimics a small GTPase, implying that the
primary role of EspG during pathogenesis is to promote actin
remodeling. Rather than recruiting a small GTPase, EPEC
circumvent the standard PAK activation mechanism (Germane
and Spiller, 2011). EspG, by mimicking the function of diverse
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small GTPases related to the actin cytoskeleton, is able to alter the
balance of the formation of diverse actin structures (Hardwidge
et al., 2005).
Interestingly, EspG exploits GEF-H1 (a nucleotide exchanger
factor) for inducing stress fibers formation during EPEC
infection. EspG is associated to actin, resulting in the disruption
of the microtubules network. GEF-H1 changes to its active form
as a result of its dissociation of the microtubules network. Active
GEF-H1 promotes the GTP binding to RhoA, resulting in RhoA
activation. Activation of ROCK, that is localized downstream
of the RhoA signaling pathway, induces the actin stress fibers
assembly (Matsuzawa et al., 2004).
Although, the exact mechanism by which EspG induces
microtubule disassembly is unknown yet, it has been reported
that EspG directly interacts with tubulin (Hardwidge et al.,
2005). EspG-tubulin interaction was also detected in epithelial
cells and correlated with the induction of destabilization
of microtubules in vitro. These events lead to destruction
of the microtubule networks beneath adherent bacteria
on epithelial cells (Matsuzawa et al., 2004; Hardwidge
et al., 2005). Furthermore, proteins extracted from EPEC-
infected cells showed a corresponding loss of α-tubulin.
Additionally, ectopic expression of EspG in epithelial cells
caused microtubule disruption. Interestingly, mutation of both
espG and espG2 significantly delayed the kinetics of TEER drop
and complementation of this double mutant with espG alone
restored the EPEC-induced decrease in TEER (Tomson et al.,
2005). The distribution of occludin from TJs was used as a
marker of TJ integrity in Caco-2 cells infected with EPEC wild
type and with a double mutant in espG and espG2. The double
mutant induced a lesser amount of occludin accumulation
in the cytoplasm than EPEC wild type. The impact of EspG
on the TJs was not only restricted to occludin; ZO-1 and
claudin-1/2 were also disturbed. Furthermore, to evaluate the
role of EspG in the TJ restoration in calcium switch assays,
Caco-2 monolayers were infected with espG double mutant and
wild type strains. 1espG1/G2-infected monolayer significantly
recovered more barrier function (78 vs. 62% in wild type infected
cells), suggesting that intact microtubule networks promote TJ
recovery after EPEC infection (Glotfelty et al., 2014). These data
demonstrate that occludin traffics on microtubules and that
microtubule disruption perturbs TJs structure and function.
Golgi apparatus dispersion is a well-known indicator of the
loss of microtubule network, and interestingly, EPEC EspG
has been located into the Golgi apparatus (Selyunin et al.,
2011; Glotfelty et al., 2014). Similar results were found using
EHEC EspG. EHEC EspG interacts with GM130, a protein
strongly attached to cis-Golgi membrane that is also related
to maintaining the structure of the cis-Golgi (Clements et al.,
2011). Additionally, it has been notice that Golgi destabilization
prevents the traffic of membrane receptors in cell infected with
EHEC (Clements et al., 2014). In the context of infection,
epithelial cells infected with the mutant strain (1espG/espG2)
retained giantin staining, a Golgi specific marker, predominantly
perinuclear. In contrast, infection with the wild type strain
induced the dispersion of Golgi marker (Glotfelty et al., 2014).
Thus, EspG may use various alternatives for disrupting the TJ
integrity; either by disruption of microtubule network, or by
inhibiting the traffic of new TJ proteins from Golgi apparatus
to plasma membrane. More studies are needed for further
understand the mechanism of TJ disruption mediated by EspG
and its relationship with the diarrhea produced by EPEC/EHEC.
NON-LEE ENCODED EFFECTORS
Genes for the non-LEE encoded effectors are clustered in six
pathogenicity islands along the genome. The genes of these
effectors are found flanked by genes related to phages and/or
transposons, implying that they were acquired by horizontal
transfer (Dean and Kenny, 2009).
NleA
The first identified non-LEE-encoded effector of A/E pathogens
that is secreted by the T3SS was NleA (Non-LEE encoded effector
A). It was firstly described in EHECO157:H7 and then in all other
A/E pathogens, including EPEC and C. rodentium (Gruenheid
et al., 2004). NleA directly interacts with NLRP3 and affects the
deubiquitination of NLRP3, a sensor molecule that has a central
role in the inflammasome formation. This interaction reduces
NLRP3 deubiquitination and the inflammasome formation.
Accumulation of ubiquitinated NLRP3 decreases the activation
of caspase-1 and the secretion of inflammatory IL-1β cytokines
related with amplifying inflammation (Yen et al., 2015). During
the inflammation process, disruption of TJ strands is one of
the major contributions during the pathogenesis of intestinal
diseases; mucosal immune activation is altered in response to
increased epithelial permeability (Edelblum and Turner, 2009).
Although, NleA produces a reduction in the inflammatory
response during EPEC infection, this effector also produces a
contrary phenomenon that is TJ disruption. A NleA-dependent
decrease in TEER and concurrent disruption of TJ strands
was observed in EPEC-infected epithelial cells. In Caco-2 cells
infected with EPEC wild type, ZO-1 and occludin redistribution
was detected but not in cells infected with EPEC1nleA,
indicating that NleA is required for disruption of TJ strands
during EPEC infection (Thanabalasuriar et al., 2010b). In order
to cause TJ disruption, NleA primarily needs to direct to the
Golgi apparatus. NleA has been located inside the Golgi and
its localization in the Golgi depends on a consensus class I
PDZ binding motif, ETRV, which is conserved among all A/E
pathogens (Lee et al., 2008).
Once in the Golgi, NleA interacts and inhibits COPII (Coat
complex protein) functions. COPII complex is formed byGTPase
Sar1, the inner layer coat components Sec23 and Sec24, and the
outer layer coat components Sec13 and Sec31. These subunits
conjunctly work to produce vesicles in the exit sites of the
endoplasmic reticulum, while specific cargo selection is mainly
executed by Sec21 (Venditti et al., 2014). Recently, it has been
found that a key component of the TJ integrity is the traffic
mediated by COPII. Knock-down of COPII components in
epithelial cells is sufficient to cause delocalization of ZO-1 and
occludin from the epithelial cell periphery, indicating that the
replacement of TJ proteins is essential to maintain its integrity
(Thanabalasuriar et al., 2013). During EPEC infection, it has been
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found that NleA compromises the Sec23/Sec24 complex through
the interaction with Sec24 subunit. While NleA expression in
CHO cells reduces 50% the secretion of alkaline phosphatase,
as a result of manipulation of the secretion of proteins in host
cells, and NleA interacts with the four paralogs of Sec24 (Sec24A,
Sec24B, Sec24C, and Sec24D) (Kim et al., 2007). The last 40
amino acids of the C-terminal of NleA are essential for these
interactions (Venditti et al., 2014). Within this region, two motifs
are important for binding the different Sec24 paralogs: (i) the
amino acids 435–437 (residues IIQ) are crucial for Sec24A/B
interaction, but less important for interaction to Sec24C/D; (ii)
contrary, mutation of isoleucines 414 and 416 to alanine had
a large effect on NleA-Sec24C/D interaction, but do not affect
interaction with Sec24A/B. The NleAmutants NleAI414A/I416A
and NleAI414A/I416A/1IIQ transfected in HeLa cells do not
co-localized with the giantin Golgi marker as the native NleA
does. Additionally, NleAI414A/I416A/1IIQ mutant showed a
diminished binding to all four mammalian Sec24 paralogs
(Thanabalasuriar et al., 2012).
Murine models have been useful tools to understand the role
of NleA along A/E pathogen infection.Mice infected with a strain
of C. rodentium engineered to express NleAI414A/I416A/1IIQ
instead of native NleA was completely avirulent in mice,
providing strong evidence that Sec24 interaction with NleA
is critical for bacteria virulence (Thanabalasuriar et al., 2012).
While the same susceptible C3H/HeOuJ mice infected with C.
rodentium showed virtually no localized staining of claudin-
3 in the TJs. Conversely, mice infected with ∆nleA or
NleAI414A/I416A/1IIQ strains showed a claudin-3 staining
localized in TJs, even at sites of bacterial adhesion. FITC-dextran
permeability assays showed that mice infected with the wild
type strain had significantly more FITC-dextran in their serum
than those mice infected with1nleA or NleAI414A/I416A/1IIQ
mutants. Similarly, mice infected with wild type strain had
increased fecal water content and decreased amount of solid feces
in their colons compared with uninfected mice. In contrast, mice
infected with 1nleA or NleAI414A/I416A/1IIQ had solid fecal
pellets in their colon and had similar fecal water contents as
uninfected mice (Thanabalasuriar et al., 2013).
According to these data, NleA and its interaction with
components of COPII complex promotes the disassembly of the
TJ. And the disassembly is tightly correlated with the production
of diarrhea in murine models.
EspM
Tobe et al. exploited a bioinformatics approach to identify
potential effectors encoded in the completed genome sequence
of the EHEC Sakai strain, and found two additional members
of the Map IpgB family (EspM1 and EspM2), both of which are
translocated by the T3SS and encoded outside of LEE. EspM
is highly frequent in EPEC and EHEC and belongs to effectors
withWxxxEmotifs, which have the capability for activating small
GTases of Rho type (Arbeloa et al., 2009). Infection of Swiss 3T3
cells with EspM expressing EPEC induces stress fiber formation,
and this depends on a conserved Trp residue (W70) of EspM, an
effect that is shared between the two variants of EspM, EspM1
and EspM2. Additionally, the expression of a dominant negative
of Rho inhibits the formation of stress fibers mediated by EspM.
These results indicate that EspM modulates the actin dynamics
through the activation of the Rho signaling pathway (Arbeloa
et al., 2008). Arbeloa et al. demonstrated a direct binding of
EspM to RhoA. On the other hand, the increase of free GTP
or GDP inhibit the formation of EspM/RhoA complex in a
concentration dependent way. The interaction between EspM
and RhoA increases the nucleotide exchange, corroborating the
GEF activity displayed by EspM.
During the infection, EspM acts as a repressor in the
development of pedestals. Simovitch et al. found an increase
in the size of pedestals induced by an EHEC mutant strain
in espM1 and espM2 genes. On the other hand, an EPEC
strain expressing espM1 and espM2 genes was unable to develop
pedestals, involving to EspM in pedestal formation. Infection of
polarized MDCKmonolayers grown on coverslips with wild type
EHEC resulted in marked alterations in the architecture of the
cell monolayer, including the appearance of cells that bulge out
of the monolayer and assume a round morphology. In contrast,
the EHEC espM double mutant failed to do so. Additionally,
monolayers infected with EspM2 expressing EPEC frequently
assumed an abnormal round shape, with the main mass of
their cell body bulging out. ZO-1was frequently found to be
delocalized tomore basal regions of the polarized cells (Simovitch
et al., 2010). Additionally, ectopic expression of EspM in MDCK
cells also showed this characteristic phenotype produced by
EspM (Simovitch et al., 2010).
COOPERATIVE ACTION OF EFFECTORS
DURING DIARRHEA INDUCTION BY EPEC
AND EHEC
Effectors, either encoded inside or outside of LEE, manipulate
the host cell signaling by manifesting a high level of
multifunctionality, allowing EPEC and EHEC to colonize,
multiply, and cause diarrhea. In previous years, the processes
seen during infection with these bacteria were attributed only
to independent action of one of its multiple effectors. Today,
this concept has changed thanks to the discoveries of the
multifunctional nature of these effectors, which has allowed the
approach of new models of infection for EPEC and EHEC. These
new models have been built based on redundant, synergistic,
or antagonistic relationships of some effectors working in a
coordinated spatial and temporal manner on different host
organelles and cellular pathways during infection (Wong et al.,
2011). The first report of a synergistic activity related to the
destabilization of TJ strands, and consequently the production
of diarrhea, strongly suggests that Map and EspF synergistically
act for destabilizing the TJs. Since in the absence of one or
another there is no redistribution of occludin and only a minor
loss of TEER is induced in Caco-2 cell monolayers. Contrary,
when both proteins are expressed in EPEC wild type strain, the
effect of these effectors on the TJs (occludin redistribution) and
on the TEER are increased even more that in strains where
they are individually mutated these genes (Dean and Kenny,
2004). Although, these molecules appear to act synergistically,
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they retain some barrier disrupting activity in the absence of
each other and thus displaying partial redundancy. However,
in a murine model using C. rodentium as the pathogen agent
and comparing with Map, EspF is more relevant for disassembly
of TJs (redistribution of claudin-1, claudin-3, and claudin-5;
Guttman et al., 2006).
In 2010, Thanabalasuriar et al. reported that NleA, EspF,
and Map manifest a synergistic action on T84 cell monolayers.
The TEER of monolayers infected with the EPEC1nleA strain
decreased 27%, as those infected with the EPEC1espF strain.
When the cell monolayers were infected with the EPEC1nleA
strain complemented with nleA gene, this strain recovered the
capability to decrease the TEER in a 71%, a similar to the
wild type strain infection. These data indicate that NleA is as
important as EspF in the TJ disruption. The hypothesis of the
synergism of these effectors was tested when the deficiencies in
these effectors were complemented in trans for producing TJ
disassembly. Cells co-infected with EPEC1nleA and EPEC1espF
showed a decrease in the TEER similar to the cells co-
infected with EPEC1nleA and EPEC1map strains. Similarly, the
redistribution of the proteins ZO-1 and occludin was inhibited
if one of these three proteins was lacking, and contrarily, this
redistribution was recovered using the same combination of
strains in co-infection (Thanabalasuriar et al., 2010b). From these
data, a new model for the synergistic effect of EPEC/EHEC
effectors related to TJ disassembly has been proposed. In this
model, in uninfected cells some of the TJ proteins are delivered
to TJ structures through the COPII-dependent pathways. When
cells are infected with EPEC wild type, the EspF and Map activity
result in the removal of proteins from TJs, while NleA blocks
the delivery of newly synthesized TJ proteins by the inhibition
of COPII. In cells infected with EPEC1espF, NleA blocks the
delivery of newly synthesized TJ proteins by inhibiting COPII,
but TJs are not disassembled due to a lack of EspF/Map activity.
In cells infected with EPEC1nleA, EspF, and Map activity result
in the removal of proteins from TJs but TJs are repaired via
the delivery of newly synthesized TJ proteins using COPII-
dependent pathways (Thanabalasuriar et al., 2010a). Although
the mechanism used by these effectors to generate TJ disruption
is poorly understood, it can be noticed that they exhibit an
particular “all or nothing” phenotype, in which, if one of these
three effectors is eliminated the ability of the bacteria to disrupt
TJs is impaired. Therefore, the exact mechanism used by each
individual effector may be very elusive (Thanabalasuriar et al.,
2013).
REMARKABLE CONCLUSIONS
Mucosal surfaces are a portal of entry for many pathogens and
the intestinal epithelium represents a surface of about 400 m2. In
the case of extracellular enterobacteria one of the main challenges
is to manipulate the selectively permeable barrier that represent
the intestinal epithelium in order to colonize and survive. As
extracellular bacteria the paracellular pathwaymight be a relevant
target rather than the intracellular pathway. The paracellular
pathway implies the cell junction, and the epithelial cells are
held together by the apical junctional complexes, consisting of
AJs and TJs, and by underlying desmosomes. Among these cell
junctions, EPEC and EHEC mainly affect the TJs. Although
the TJ structure is a large protein complex, the major types
are the claudins and the occludins. These are associated with
different peripheral membrane proteins, such as ZO-1 located
on the intracellular side of plasma membrane, which anchor
the strands to the actin component of the cytoskeleton. Thus,
TJs join together the cytoskeletons of adjacent cells. One of TJ
functions is helping tomaintain the polarity of cells by preventing
the lateral diffusion of integral membrane proteins between
the apical and lateral/basal surfaces, allowing the specialized
functions of each surface to be preserved. Thus, TJ integrity
depends on various cell functions, such as actin cytoskeleton as
mentioned above, microtubule network for vesicular trafficking
including endocytosis of TJ proteins for replacement, membrane
integrity, inflammation, and cell survival. EPEC and EHEC
effectors target most of these functions. Interestingly, LEE
and non-LEE effectors disrupt the TJ strands through indirect
mechanisms of TJ disassembly by interfering with occludin
dephosphorylation, actin rearrangement, microtubule network
disruption, regulation of actin polymerization and disruption of
vesicular trafficking (Figure 2). Nevertheless, EPEC and EHEC
exploit the TJ dynamics to open them, and in consequence,
the bacteria cause diarrhea. EPEC and EHEC secrete effectors
classified as multitask proteins, indicating that they are not
only related to the production of diarrhea but also with the
manipulation of other cellular processes. Remarkably, these
bacterial effectors mimic host proteins to manipulate the
signaling pathways, for instance acting as GEF, Rho, etc. Thus,
new regions or motifs inside these effector proteins, which are
related to the manipulation of cellular processes, are constantly
described revealing new ways for which EPEC and EHEC
exploit cellular processes for bacterial colonization, adhesion, and
propagation.
In the past decade, it has been clear that the integration of
the effects of multiple effectors (LEE and non-LEE effectors) is
a difficult task. Most of the effectors protein contains functional
motifs, which mimicking cell functions, such as binding motifs
to SH3 or PDZ domains. Most effectors are multifunctional
proteins and EspF is one of the best examples, which can act
in the cytoplasm, in the mitochondria or in the nucleolus.
Furthermore, the multifunctional nature of these effectors have
allowed to build new models based on redundant, synergistic
or antagonistic relationship of some effectors working in a
coordinated spatial and temporal manner on different host
organelles and cellular pathways during EPEC and EHEC
infection.
AUTHOR CONTRIBUTIONS
PU-S, OG-L, FN-G contributed to the writing of this review. All
authors read and approved the final manuscript.
ACKNOWLEDGMENTS
This work was supported by a grant from Consejo Nacional de
Ciencia y Tecnología (CONACYT; 128490 and 221130) to FN-G.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9 August 2016 | Volume 6 | Article 87
Ugalde-Silva et al. Tight Junction Disruption by EPEC and EHEC
REFERENCES
Abe, A., de Grado, M., Pfuetzner, R. A., Sanchez-Sanmartin, C., Devinney, R.,
Puente, J. L., et al. (1999). Enteropathogenic Escherichia coli translocated
intimin receptor, Tir, requires a specific chaperone for stable secretion. Mol.
Microbiol. 33, 1162–1175. doi: 10.1046/j.1365-2958.1999.01558.x
Alto, N. M., Shao, F., Lazar, C. S., Brost, R. L., Chua, G., Mattoo, S., et al. (2006).
Identification of a bacterial type III effector family with G protein mimicry
functions. Cell 124, 133–145. doi: 10.1016/j.cell.2005.10.031
Alto, N. M., Weflen, A. W., Rardin, M. J., Yarar, D., Lazar, C. S., Tonikian, R.,
et al. (2007). The type III effector EspF coordinates membrane trafficking by
the spatiotemporal activation of two eukaryotic signaling pathways. J. Cell Biol.
178, 1265–1278. doi: 10.1083/jcb.200705021
Amieva, M. R., Vogelmann, R., Covacci, A., Tompkins, L. S., Nelson, W. J., and
Falkow, S. (2003). Disruption of the epithelial apical-junctional complex by
Helicobacter pyloriCagA. Science 300, 1430–1434. doi: 10.1126/science.1081919
Arbeloa, A., Blanco, M., Moreira, F. C., Bulgin, R., López, C., Dahbi, G.,
et al. (2009). Distribution of espM and espT among enteropathogenic and
enterohaemorrhagic Escherichia coli. J. Med. Microbiol. 58(Pt 8), 988–995. doi:
10.1099/jmm.0.010231-0
Arbeloa, A., Bulgin, R. R., MacKenzie, G., Shaw, R. K., Pallen, M. J., Crepin,
V. F., et al. (2008). Subversion of actin dynamics by EspM effectors of
attaching and effacing bacterial pathogens. Cell. Microbiol. 10, 1429–1441. doi:
10.1111/j.1462-5822.2008.01136.x
Berger, C. N., Crepin, V. F., Jepson, M. A., Arbeloa, A., and Frankel, G. (2009).
The mechanisms used by enteropathogenic Escherichia coli to control filopodia
dynamics. Cell. Microbiol. 11, 309–322. doi: 10.1111/j.1462-5822.2008.01254.x
Blasche, S., Arens, S., Ceol, A., Siszler, G., Schmidt, M. A., Häuser, R., et al. (2014).
The EHEC-host interactome reveals novel targets for the translocated intimin
receptor. Sci. Rep. 4:7531. doi: 10.1038/srep07531
Bosi, E., Molteni, L., Radaelli, M. G., Folini, L., Fermo, I., Bazzigaluppi, E., et al.
(2006). Increased intestinal permeability precedes clinical onset of type 1
diabetes. Diabetologia 49, 2824–2827. doi: 10.1007/s00125-006-0465-3
Broer, S. (2008). Amino acid transport across mammalian intestinal and renal
epithelia. Physiol. Rev. 88, 249–286. doi: 10.1152/physrev.00018.2006
Campellone, K. G., Siripala, A. D., Leong, J. M., and Welch, M. D. (2012).
Membrane-deforming proteins play distinct roles in actin pedestal biogenesis
by enterohemorrhagic Escherichia coli. J. Biol. Chem. 287, 20613–20624. doi:
10.1074/jbc.M112.363473
Chalmers, A. D., and Whitley, P. (2012). Continuous endocytic recycling of
tight junction proteins: how and why? Essays Biochem. 53, 41–54. doi:
10.1042/bse0530041
Chen, S., Einspanier, R., and Schoen, J. (2015). Transepithelial electrical resistance
(TEER): a functional parameter to monitor the quality of oviduct epithelial
cells cultured on filter supports. Histochem. Cell Biol. 144, 509–515. doi:
10.1007/s00418-015-1351-1
Clements, A., Smollett, K., Lee, S. F., Hartland, E. L., Lowe, M., and Frankel, G.
(2011). EspG of enteropathogenic and enterohemorrhagic E. coli binds the
Golgi matrix protein GM130 and disrupts the Golgi structure and function.
Cell. Microbiol. 13, 1429–1439. doi: 10.1111/j.1462-5822.2011.01631.x
Clements, A., Stoneham, C. A., Furniss, R. C. D., and Frankel, G. (2014).
Enterohaemorrhagic Escherichia coli inhibits recycling endosome function
and trafficking of surface receptors. Cell. Microbiol. 16, 1693–1705. doi:
10.1111/cmi.12319
Dean, P., and Kenny, B. (2004). Intestinal barrier dysfunction by enteropathogenic
Escherichia coli is mediated by two effector molecules and a bacterial surface
protein.Mol. Microbiol. 54, 665–675. doi: 10.1111/j.1365-2958.2004.04308.x
Dean, P., and Kenny, B. (2009). The effector repertoire of enteropathogenic E.
coli: ganging up on the host cell. Curr. Opin. Microbiol. 12, 101–109. doi:
10.1016/j.mib.2008.11.006
Dong, N., Zhu, Y., Lu, Q., Hu, L., Zheng, Y., and Shao, F. (2012). Structurally
distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to
counteract host defenses. Cell 150, 1029–1041. doi: 10.1016/j.cell.2012.06.050
Edelblum, K. L., and Turner, J. R. (2009). The tight junction in inflammatory
disease: communication breakdown. Curr. Opin. Pharmacol. 9, 715–720. doi:
10.1016/j.coph.2009.06.022
Elliott, S. J., Krejany, E. O., Mellies, J. L., Robins-Browne, R. M., Sasakawa, C.,
and Kaper, J. B. (2001). EspG, a novel type III system-secreted protein from
enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri.
Infect. Immun. 69, 4027–4033. doi: 10.1128/IAI.69.6.4027-4033.2001
Elliott, S. J., O’Connell, C. B., Koutsouris, A., Brinkley, C., Donnenberg, M. S.,
Hecht, G., et al. (2002). A gene from the locus of enterocyte effacement that
is required for enteropathogenic Escherichia coli to increase tight-junction
permeability encodes a chaperone for EspF. Infect. Immun. 70, 2271–2277. doi:
10.1128/IAI.70.5.2271-2277.2002
Elliott, S. J., Sperandio, V., Giron, J. A., Shin, S., Mellies, J. L., Wainwright, L.,
et al. (2000). The locus of enterocyte effacement (LEE)-encoded regulator
controls expression of both LEE- and non-LEE-encoded virulence factors in
enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 68,
6115–6126. doi: 10.1128/IAI.68.11.6115-6126.2000
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wolk, B., et al.
(2007). Claudin-1 is a hepatitis C virus co-receptor required for a late step in
entry. Nature 446, 801–805. doi: 10.1038/nature05654
Farhadi, A., Banan, A., Fields, J., and Keshavarzian, A. (2003). Intestinal barrier:
an interface between health and disease. J. Gastroenterol. Hepatol. 18, 479–497.
doi: 10.1046/j.1440-1746.2003.03032.x
Ferraris, R. P., and Diamond, J. (1997). Regulation of intestinal sugar transport.
Physiol. Rev. 77, 257–302.
Furuse, M., Fujita, K., Hiiragi, T., Fujimoto, K., and Tsukita, S. (1998). Claudin-
1 and -2: Novel integral membrane proteins localizing at tight junctions
with no sequence similarity to occludin. J. Cell Biol. 141, 1539–1550. doi:
10.1083/jcb.141.7.1539
Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S.,
et al. (1993). Occludin: a novel integral membrane protein localizing at tight
junctions. J. Cell Biol. 123(6 Pt 2), 1777–1788. doi: 10.1083/jcb.123.6.1777
Germane, K. L., and Spiller, B.W. (2011). Structural and functional studies indicate
that the EPEC effector, EspG, directly binds p21-activated kinase. Biochemistry
50, 917–919. doi: 10.1021/bi1020138
Glotfelty, L. G., Zahs, A., Hodges, K., Shan, K., Alto, N.M., andHecht, G. A. (2014).
Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute
to tight junction perturbation and inhibit restoration. Cell. Microbiol. 16,
1767–1783. doi: 10.1111/cmi.12323
González-Mariscal, L., Betanzos, A., Nava, P., and Jaramillo, B. E. (2003). Tight
junction proteins. Prog. Biophys. Mol. Biol. 81, 1–44. doi: 10.1016/S0079-
6107(02)00037-8
Gruenheid, S., Sekirov, I., Thomas, N. A., Deng, W., O’Donnell, P., Goode,
D., et al. (2004). Identification and characterization of NleA, a non-
LEE-encoded type III translocated virulence factor of enterohaemorrhagic
Escherichia coli O157:H7. Mol. Microbiol. 51, 1233–1249. doi: 10.1046/j.1365-
2958.2003.03911.x
Guttman, J. A., Li, Y., Wickham, M. E., Deng, W., Vogl, A. W., and Finlay, B. B.
(2006). Attaching and effacing pathogen-induced tight junction disruption in
vivo. Cell. Microbiol. 8, 634–645. doi: 10.1111/j.1462-5822.2005.00656.x
Hanajima-Ozawa, M., Matsuzawa, T., Fukui, A., Kamitani, S., Ohnishi, H., Abe, A.,
et al. (2007). Enteropathogenic Escherichia coli, Shigella flexneri, and Listeria
monocytogenes recruit a junctional protein, zonula occludens-1, to actin tails
and pedestals. Infect. Immun. 75, 565–573. doi: 10.1128/IAI.01479-06
Hardwidge, P. R., Deng, W., Vallance, B. A., Rodriguez-Escudero, I., Cid,
V. J., Molina, M., et al. (2005). Modulation of host cytoskeleton function
by the enteropathogenic Escherichia coli and Citrobacter rodentium effector
protein EspG. Infect. Immun. 73, 2586–2594. doi: 10.1128/IAI.73.5.2586-2594.
2005
Hartland, E. L., Daniell, S. J., Delahay, R. M., Neves, B. C., Wallis, T., Shaw, R.
K., et al. (2000). The type III protein translocation system of enteropathogenic
Escherichia coli involves EspA-EspB protein interactions. Mol. Microbiol. 35,
1483–1492. doi: 10.1046/j.1365-2958.2000.01814.x
Holmes, A., Muhlen, S., Roe, A. J., and Dean, P. (2010). The EspF effector,
a bacterial pathogen’s Swiss army knife. Infect. Immun. 78, 4445–4453. doi:
10.1128/IAI.00635-10
Ikenouchi, J., Furuse, M., Furuse, K., Sasaki, H., Tsukita, S. S., and Tsukita, S. S.
(2005). Tricellulin constitutes a novel barrier at tricellular contacts of epithelial
cells. J. Cell Biol. 171, 939–945. doi: 10.1083/jcb.200510043
Kenny, B., Ellis, S., Leard, A. D., Warawa, J., Mellor, H., and Jepson, M. A.
(2002). Co-ordinate regulation of distinct host cell signalling pathways by
multifunctional enteropathogenic Escherichia coli effector molecules. Mol.
Microbiol. 44, 1095–1107. doi: 10.1046/j.1365-2958.2002.02952.x
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 10 August 2016 | Volume 6 | Article 87
Ugalde-Silva et al. Tight Junction Disruption by EPEC and EHEC
Kim, J., Thanabalasuriar, A., Chaworth-Musters, T., Fromme, J. C., Frey, E. A.,
Lario, P. I., et al. (2007). The bacterial virulence factor NleA inhibits cellular
protein secretion by disrupting mammalian COPII function. Cell Host Microbe
2, 160–171. doi: 10.1016/j.chom.2007.07.010
Kissoon-Singh, V., Moreau, F., Trusevych, E., and Chadee, K. (2013).
Entamoeba histolytica exacerbates epithelial tight junction permeability and
proinflammatory responses inMuc2(-/-) mice.Am. J. Pathol. 182, 852–865. doi:
10.1016/j.ajpath.2012.11.035
Knutton, S., Lloyd, D. R., andMcNeish, A. S. (1987). Adhesion of enteropathogenic
Escherichia coli to human intestinal enterocytes and cultured human intestinal
mucosa. Infect. Immun. 55, 69–77.
Kraehenbuhl, J. P., Pringault, E., andNeutra,M. R. (1997). Review article: intestinal
epithelia and barrier functions. Aliment. Pharmacol. Ther. 11(Suppl 3), 3–8.
discussion: 8–9. doi: 10.1111/j.1365-2036.1997.tb00803.x
Kunzelmann, K., and Mall, M. (2002). Electrolyte transport in the mammalian
colon: mechanisms and implications for disease. Physiol. Rev. 82, 245–289. doi:
10.1152/physrev.00026.2001
Lee, S. F., Kelly, M., McAlister, A., Luck, S. N., Garcia, E. L., Hall, R. A., et al.
(2008). A C-terminal class I PDZ binding motif of EspI/NleA modulates the
virulence of attaching and effacing Escherichia coli and Citrobacter rodentium.
Cell. Microbiol. 10, 499–513. doi: 10.1111/j.1462-5822.2007.01065.x
Lee, S. H. (2015). Intestinal permeability regulation by tight junction: implication
on inflammatory bowel diseases. Intest. Res. 13, 11–18. doi: 10.5217/ir.2015.
13.1.11
Ma, C., Wickham, M. E., Guttman, J. A., Deng, W., Walker, J., Madsen, K. L., et al.
(2006). Citrobacter rodentium infection causes both mitochondrial dysfunction
and intestinal epithelial barrier disruption in vivo: role of mitochondrial
associated protein (Map). Cell. Microbiol. 8, 1669–1686. doi: 10.1111/j.1462-
5822.2006.00741.x
Madgula, V. L., Avula, B., Reddy, V. L. N., Khan, I. A., and Khan, S. I. (2007).
Transport of decursin and decursinol angelate across Caco-2 and MDR-
MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier
permeability. Planta Med. 73, 330–335. doi: 10.1055/s-2007-967137
Martin-Padura, I. S., Lostaglio, S., Schneemann, M., Williams, L., Romano, M.,
Fruscella, P., et al. (1998). Junctional adhesion molecule, a novel member
of the immunoglobulin superfamily that distributes at intercellular junctions
and modulates monocyte transmigration. J. Cell Biol. 142, 117–127. doi:
10.1083/jcb.142.1.117
Matsuzawa, T., Kuwae, A., Yoshida, S., Sasakawa, C., and Abe, A. (2004).
Enteropathogenic Escherichia coli activates the RhoA signaling pathway via
the stimulation of GEF-H1. EMBO J. 23, 3570–3582. doi: 10.1038/sj.emboj.
7600359
McDaniel, T. K., and Kaper, J. B. (1997). A cloned pathogenicity island
from enteropathogenic Escherichia coli confers the attaching and effacing
phenotype on E. coli K-12. Mol. Microbiol. 23, 399–407. doi: 10.1046/j.1365-
2958.1997.2311591.x
McLaughlin, J., Padfield, P. J., Burt, J. P., and O’Neill, C. A. (2004). Ochratoxin
A increases permeability through tight junctions by removal of specific
claudin isoforms. Am. J. Physiol. Cell Physiol. 287, C1412–C1417. doi:
10.1152/ajpcell.00007.2004
McNamara, B. P., and Donnenberg, M. S. (1998). A novel proline-rich protein,
EspF, is secreted from enteropathogenic Escherichia coli via the type III
export pathway. FEMS Microbiol. Lett. 166, 71–78. doi: 10.1111/j.1574-
6968.1998.tb13185.x
McNamara, B. P., Koutsouris, A., O’Connell, C. B., Nougayrede, J. P., Donnenberg,
M. S., and Hecht, G. (2001). Translocated EspF protein from enteropathogenic
Escherichia coli disrupts host intestinal barrier function. J. Clin. Invest. 107,
621–629. doi: 10.1172/JCI11138
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci,
R., et al. (2009). Increased intestinal permeability and tight junction
alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877–1887. doi:
10.1002/hep.22848
Muza-Moons, M. M., Schneeberger, E. E., and Hecht, G. A. (2004).
Enteropathogenic Escherichia coli infection leads to appearance of aberrant
tight junctions strands in the lateral membrane of intestinal epithelial cells.
Cell. Microbiol. 6, 783–793. doi: 10.1111/j.1462-5822.2004.00404.x
Navarro-Garcia, F., Serapio-Palacios, A., Ugalde-Silva, P., Tapia-Pastrana, G.,
and Chavez-Duenas, L. (2013). Actin cytoskeleton manipulation by effector
proteins secreted by diarrheagenic Escherichia coli pathotypes. Biomed Res. Int.
2013:374395. doi: 10.1155/2013/374395
Nekrasova, O., and Green, K. J. (2013). Desmosome assembly and dynamics.
Trends Cell Biol. 23, 537–546. doi: 10.1016/j.tcb.2013.06.004
Orchard, R. C., Kittisopikul, M., Altschuler, S. J., Wu, L. F., Suel, G.M., and Alto, N.
M. (2012). Identification of F-actin as the dynamic hub in a microbial-induced
GTPase polarity circuit. Cell 148, 803–815. doi: 10.1016/j.cell.2011.11.063
Pastorelli, L., De Salvo, C., Mercado, J. R., Vecchi, M., and Pizarro, T. T. (2013).
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal
inflammation: lessons learned from animal models and human genetics. Front.
Immunol. 4:280. doi: 10.3389/fimmu.2013.00280
Peralta-Ramirez, J., Hernandez, J. M., Manning-Cela, R., Luna-Munoz, J., Garcia-
Tovar, C., Nougayrede, J. P., et al. (2008). EspF Interacts with nucleation-
promoting factors to recruit junctional proteins into pedestals for pedestal
maturation and disruption of paracellular permeability. Infect. Immun. 76,
3854–3868. doi: 10.1128/IAI.00072-08
Philpott, D. J., Ackerley, C. A., Kiliaan, A. J., Karmali, M. A., Perdue, M.
H., and Sherman, P. M. (1997). Translocation of verotoxin-1 across T84
monolayers: mechanism of bacterial toxin penetration of epithelium. Am. J.
Physiol. Gastrointest. Liver Physiol. 273, G1349–G1358.
Philpott, D. J., McKay, D. M., Mak, W., Perdue, M. H., and Sherman, P. M. (1998).
Signal transduction pathways involved in enterohemorrhagic Escherichia
coli-induced alterations in T84 epithelial permeability. Infect. Immun. 66,
1680–1687.
Philpott, D. J., McKay, D. M., Sherman, P. M., and Perdue, M. H. (1996). Infection
of T84 cells with enteropathogenic Escherichia coli alters barrier and transport
functions. Am. J. Physiol. 270(4 Pt 1), G634–G645.
Ploss, A., Evans, M. J., Gaysinskaya, V. A., Panis, M., You, H., de Jong, Y. P., et al.
(2009). Human occludin is a hepatitis C virus entry factor required for infection
of mouse cells. Nature 457, 882–886. doi: 10.1038/nature07684
Roxas, J. L., Koutsouris, A., Bellmeyer, A., Tesfay, S., Royan, S., Falzari, K.,
et al. (2010). Enterohemorrhagic E. coli alters murine intestinal epithelial tight
junction protein expression and barrier function in a Shiga toxin independent
manner. Lab. Invest. 90, 1152–1168. doi: 10.1038/labinvest.2010.91
Salvador, F. A., Hernandes, R. T., Vieira, M. A., Rockstroh, A. C., and Gomes, T. A.
(2014). Distribution of non-LEE-encoded type 3 secretion system dependent
effectors in enteropathogenic Escherichia coli. Braz. J. Microbiol. 45, 851–855.
doi: 10.1590/S1517-83822014000300014
Selyunin, A. S., Sutton, S. E., Weigele, B. A., Reddick, L. E., Orchard, R. C., Bresson,
S. M., et al. (2011). The assembly of a GTPase-kinase signalling complex by a
bacterial catalytic scaffold. Nature 469, 107–111. doi: 10.1038/nature09593
Shiﬄett, D. E., Clayburgh, D. R., Koutsouris, A., Turner, J. R., and Hecht, G. A.
(2005). Enteropathogenic E. coli disrupts tight junction barrier function and
structure in vivo. Lab. Invest. 85, 1308–1324. doi: 10.1038/labinvest.3700330
Simonovic, I., Rosenberg, J., Koutsouris, A., and Hecht, G. (2000).
Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin
from intestinal epithelial tight junctions. Cell. Microbiol. 2, 305–315. doi:
10.1046/j.1462-5822.2000.00055.x
Simovitch, M., Sason, H., Cohen, S., Zahavi, E. E., Melamed-Book, N., Weiss,
A., et al. (2010). EspM inhibits pedestal formation by enterohaemorrhagic
Escherichia coli and enteropathogenic E. coli and disrupts the architecture
of a polarized epithelial monolayer. Cell. Microbiol. 12, 489–505. doi:
10.1111/j.1462-5822.2009.01410.x
Spitz, J., Yuhan, R., Koutsouris, A., Blatt, C., Alverdy, J., and Hecht, G. (1995).
Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers
diminishes barrier function. Am. J. Physiol. 268(2 Pt 1), G374–G379.
Suzuki, T. (2013). Regulation of intestinal epithelial permeability by tight
junctions. Cell. Mol. Life Sci. 70, 631–659. doi: 10.1007/s00018-012-1070-x
Thanabalasuriar, A., Bergeron, J., Gillingham, A., Mimee, M., Thomassin, J. L.,
Strynadka, N., et al. (2012). Sec24 interaction is essential for localization
and virulence-associated function of the bacterial effector protein NleA. Cell.
Microbiol. 14, 1206–1218. doi: 10.1111/j.1462-5822.2012.01789.x
Thanabalasuriar, A., Kim, J., and Gruenheid, S. (2013). The inhibition of COPII
trafficking is important for intestinal epithelial tight junction disruption
during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
Microbes Infect. 15, 738–744. doi: 10.1016/j.micinf.2013.05.001
Thanabalasuriar, A., Koutsouris, A., Hecht, G., and Gruenheid, S. (2010a).
The bacterial virulence factor NleA’s involvement in intestinal tight
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11 August 2016 | Volume 6 | Article 87
Ugalde-Silva et al. Tight Junction Disruption by EPEC and EHEC
junction disruption during enteropathogenic E. coli infection is independent
of its putative PDZ binding domain. Gut Microbes 1, 114–118. doi:
10.4161/gmic.1.2.11685
Thanabalasuriar, A., Koutsouris, A., Weflen, A., Mimee, M., Hecht, G., and
Gruenheid, S. (2010b). The bacterial virulence factor NleA is required
for the disruption of intestinal tight junctions by enteropathogenic
Escherichia coli. Cell. Microbiol. 12, 31–41. doi: 10.1111/j.1462-5822.2009.
01376.x
Tomson, F. L., Viswanathan, V. K., Kanack, K. J., Kanteti, R. P., Straub, K.
V., Menet, M., et al. (2005). Enteropathogenic Escherichia coli EspG disrupts
microtubules and in conjunction with Orf3 enhances perturbation of the
tight junction barrier. Mol. Microbiol. 56, 447–464. doi: 10.1111/j.1365-
2958.2005.04571.x
Tsukita, S., Furuse, M., and Itoh, M. (2001). Multifunctional strands in tight
junctions. Nat. Rev. Mol. Cell Biol. 2, 285–293. doi: 10.1038/35067088
Turner, J. R., Rill, B. K., Carlson, S. L., Carnes, D., Kerner, R., Mrsny, R.
J., et al. (1997). Physiological regulation of epithelial tight junctions is
associated with myosin light-chain phosphorylation.Am. J. Physiol. 273(4 Pt 1),
C1378–C1385.
van der Flier, L. G., and Clevers, H. (2009). Stem cells, self-renewal, and
differentiation in the intestinal epithelium.Annu. Rev. Physiol. 71, 241–260. doi:
10.1146/annurev.physiol.010908.163145
Van Itallie, C. M., and Anderson, J. M. (2006). Claudins and epithelial
paracellular transport. Annu. Rev. Physiol. 68, 403–429. doi:
10.1146/annurev.physiol.68.040104.131404
Van Itallie, C. M., Tietgens, A. J., Krystofiak, E., Kachar, B., and Anderson,
J. M. (2015). A complex of ZO-1 and the BAR-domain protein TOCA-1
regulates actin assembly at the tight junction. Mol. Biol. Cell 26, 2769–2787.
doi: 10.1091/mbc.E15-04-0232
Venditti, R., Wilson, C., and De Matteis, M. A. (2014). Exiting the ER: what we
know and what we don’t. Trends Cell Biol. 24, 9–18. doi: 10.1016/j.tcb.2013.
08.005
Viswanathan, V. K., Koutsouris, A., Lukic, S., Pilkinton, M., Simonovic,
I., Simonovic, M., et al. (2004). Comparative analysis of EspF from
enteropathogenic and enterohemorrhagic Escherichia coli in alteration
of epithelial barrier function. Infect. Immun. 72, 3218–3227. doi:
10.1128/IAI.72.6.3218-3227.2004
Vossenkamper, A., MacDonald, T. T., and Marches, O. (2011). Always one
step ahead: how pathogenic bacteria use the type III secretion system to
manipulate the intestinal mucosal immune system. J. Inflamm. (Lond). 8:11.
doi: 10.1186/1476-9255-8-11
Wainwright, L. A., and Kaper, J. B. (1998). EspB and EspD require a specific
chaperone for proper secretion from enteropathogenic Escherichia coli. Mol.
Microbiol. 27, 1247–1260. doi: 10.1046/j.1365-2958.1998.00771.x
Walsh, S. V., Hopkins, A. M., Chen, J., Narumiya, S., Parkos, C. A., and Nusrat,
A. (2001). Rho kinase regulates tight junction function and is necessary for
tight junction assembly in polarized intestinal epithelia. Gastroenterology 121,
566–579. doi: 10.1053/gast.2001.27060
Weflen, A. W., Alto, N. M., Viswanathan, V. K., and Hecht, G. (2010). E. coli
secreted protein F promotes EPEC invasion of intestinal epithelial cells via an
SNX9-dependent mechanism.Cell. Microbiol. 12, 919–929. doi: 10.1111/j.1462-
5822.2010.01440.x
Wong, A. R., Pearson, J. S., Bright, M. D., Munera, D., Robinson, K. S., Lee, S. F.,
et al. (2011). Enteropathogenic and enterohaemorrhagic Escherichia coli: even
more subversive elements. Mol. Microbiol. 80, 1420–1438. doi: 10.1111/j.1365-
2958.2011.07661.x
Yen, H., Sugimoto, N., and Tobe, T. (2015). Enteropathogenic Escherichia coli uses
NleA to inhibit NLRP3 inflammasome activation. PLoS Pathog. 11:e1005121.
doi: 10.1371/journal.ppat.1005121
Zhang, Q., Li, Q., Wang, C., Li, N., and Li, J. (2012). Redistribution of tight
junction proteins during EPEC infection in vivo. Inflammation 35, 23–32. doi:
10.1007/s10753-010-9285-1
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Ugalde-Silva, Gonzalez-Lugo and Navarro-Garcia. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 12 August 2016 | Volume 6 | Article 87
